Unique Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.00 M
- Revenue Growth -98.44%
- Profit Growth -46.57%
- Ebitda -428.11%
- Net Worth -28.74%
- Total Assets -13.61%
About Unique Laboratories
Unique Laboratories Private Limited (ULPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 April 2007 and has a history of 17 years and nine months. Its registered office is in Kolar, Karnataka, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Velayutham Sivasubbu, Jatia Mamta, and Shashank More serve as directors at the Company.
Company Details
- Location
Kolar, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232KA2007PTC042413
- Company No.
042413
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Unique Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Velayutham Sivasubbu  | Director | 05-Apr-2007 | Current |
| Jatia Mamta | Director | 28-May-2016 | Current |
| Shashank More | Director | 19-Jul-2023 | Current |
Financial Performance of Unique Laboratories.
Unique Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.44% decrease. The company also saw a substantial fall in profitability, with a 46.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unique Laboratories?
In 2022, Unique Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hermes Laboratories Private LimitedJatia Mamta is a mutual person
Omshri Labs Private LimitedJatia Mamta and Shashank More are mutual person
Charges (Loans)
₹0
₹5.00 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Aug 2007 | Canara Bank | ₹5.00 M | Satisfied |
How Many Employees Work at Unique Laboratories?
Unlock and access historical data on people associated with Unique Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unique Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unique Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
